Preoperative dexamethasone reduces postoperative pain, nausea and vomiting following mastectomy for breast cancer

Jorge Gómez-Hernández, Alba Lorena Orozco-Alatorre, Marisela Domínguez-Contreras, Antonio Oceguera-Villanueva, Salvador Gómez-Romo, Andrea Socorro Alvarez Villaseñor, Clotilde Fuentes-Orozco, Alejandro González-Ojeda, Jorge Gómez-Hernández, Alba Lorena Orozco-Alatorre, Marisela Domínguez-Contreras, Antonio Oceguera-Villanueva, Salvador Gómez-Romo, Andrea Socorro Alvarez Villaseñor, Clotilde Fuentes-Orozco, Alejandro González-Ojeda

Abstract

Background: Dexamethasone has been reported to reduce postoperative symptoms after different surgical procedures. We evaluated the efficacy of preoperative dexamethasone in ameliorating postoperative nausea and vomiting (PONV), and pain after mastectomy.

Methods: In this prospective, double-blind, placebo-controlled study, 70 patients scheduled for mastectomy with axillary lymph node dissection were analyzed after randomization to treatment with 8 mg intravenous dexamethasone (n = 35) or placebo (n = 35). All patients underwent standardized procedures for general anesthesia and surgery. Episodes of PONV and pain score were recorded on a visual analogue scale. Analgesic and antiemetic requirements were also recorded.

Results: Demographic and medical variables were similar between groups. The incidence of PONV was lower in the dexamethasone group at the early postoperative evaluation (28.6% vs. 60%; p = 0.02) and at 6 h (17.2% vs. 45.8%; p = 0.03). More patients in the placebo group required additional antiemetic medication (21 vs. 8; p = 0.01). Dexamethasone treatment significantly reduced postoperative pain just after surgery (VAS score, 4.54 ± 1.55 vs. 5.83 ± 2.00; p = 0.004), at 6 h (3.03 ± 1.20 vs. 4.17 ± 1.24; p < 0.0005) and at 12 h (2.09 ± 0.85 vs. 2.54 ± 0.98; p = 0.04). Analgesics were required in more patients of the control group (21 vs. 10; p = 0.008). There were no adverse events, morbidity or mortality.

Conclusions: Preoperative intravenous dexamethasone (8 mg) can significantly reduce the incidence of PONV and pain in patients undergoing mastectomy with axillary dissection for breast cancer.

Trial registration number: NCT01116713.

Figures

Figure 1
Figure 1
Pain VAS score of patients in the control and study groups.

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA Cancer J Clin. 2008;58:71–96. doi: 10.3322/CA.2007.0010.
    1. DGE/SSA: Grupos etáreos. Registro Histopatológico de Neoplasias en México (RHPNM). Mexico City. 2003. CD-ROM.
    1. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology. 1992;77:162–184. doi: 10.1097/00000542-199207000-00023.
    1. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000;59:213–243. doi: 10.2165/00003495-200059020-00005.
    1. Oddby-Muhrbeck E, Jakobsson J, Andersson L, Askergren J. Postoperative nausea and vomiting: a comparison between intravenous and inhalation anaesthesia in breast surgery. Acta Anaesthesiol Scand. 1994;38:52–56. doi: 10.1111/j.1399-6576.1994.tb03837.x.
    1. Sadhasivam S, Saxena A, Kathirvel S, Kannan TR, Trikha A, Mohan V. The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy. Anesth Analg. 1999;89:1340–1345. doi: 10.1097/00000539-199912000-00002.
    1. Hammas B, Thorn SE, Wattwil M. Superior prolonged antiemetic prophylaxis with a four-drug multimodal regimen-comparison with propofol or placebo. Acta Anaesthesiol Scand. 2002;46:232–237. doi: 10.1034/j.1399-6576.2002.460302.x.
    1. White PF, Watcha MF. Are new drugs cost-effective for patients undergoing ambulatory surgery? Anesthesiology. 1993;78:2–5. doi: 10.1097/00000542-199301000-00002.
    1. Lerman J. Are antiemetics cost-effective for children? Can J Anaesth. 1995;42:263–266. doi: 10.1007/BF03010699.
    1. Aapro MS, Alberts DS. Dexamethasone as an antiemetic in patients treated with cisplatin. N Engl J Med. 1981;305:520.
    1. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002;195:694–712. doi: 10.1016/S1072-7515(02)01491-6.
    1. Wattwil M, Thorn SE, Lovqvist A, Wattwil L, Gupta A, Liljegren G. Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. Acta Anaesthesiol Scand. 2003;47:823–827. doi: 10.1034/j.1399-6576.2003.00172.x.
    1. Koivaranta M, Laara E, Snare L, Alahuhta S. A survey of postoperative nausea and vomiting. Anesthesia. 1997;52:443–449. doi: 10.1111/j.1365-2044.1997.117-az0113.x.
    1. Fujii Y. Prophylaxis of postoperative nausea and vomiting in patients scheduled for breast surgery. Clin Drug Invest. 2006;26:427–437. doi: 10.2165/00044011-200626080-00001.
    1. Apfel CC, Greim CA, Haubitz I, Goepfert C, Usadel J, Sefrin P, Roewer N. A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand. 1998;42:495–501. doi: 10.1111/j.1399-6576.1998.tb05157.x.
    1. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology. 1999;91:109–118. doi: 10.1097/00000542-199907000-00018.
    1. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusion from cross-validations between two centers. Anesthesiology. 1999;91:693–700. doi: 10.1097/00000542-199909000-00022.
    1. Smessaert A, Schehr CA, Artusio JF Jr. Nausea and vomiting in the immediate postoperative period. JAMA. 1959;170:2072–2076.
    1. Jenkins JC, Lahay D. Central mechanisms of vomiting related to catecholamine response: anaesthetic implication. Can Anaesth Soc J. 1971;18:434–441. doi: 10.1007/BF03025695.
    1. Perreault L, Normandin N, Plamondon L, Blain R, Rousseau P, Girard M, Foget G. Middle ear pressure variations during nitrous oxide-oxygen anesthesia. Can Anaesth Soc J. 1982;29:428–434. doi: 10.1007/BF03009404.
    1. Egar EI II, Saidman LJ. Hazards of nitrous oxide anesthesia in bowel obstruction and pneumothorax. Anesthesiology. 1965;26:61–66. doi: 10.1097/00000542-196501000-00011.
    1. Hartung J. Twenty-four of twenty-seven studies show a greater incidence of emesis with nitrous oxide than with alternative anesthetics. Anesth Analg. 1996;83:114–116. doi: 10.1097/00000539-199607000-00020.
    1. Vanacker BF. The impact of nitrous oxide on postoperative nausea and vomiting after desflurane anesthesia for breast surgery. Acta Anaesth Belg. 1999;50:77–81.
    1. Fernández-Guisasola J, Gómez-Arnau JI, Cabrera Y, del Valle SG. Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis. Anaesthesia. 2010;65:379–387.
    1. Sneyd JR, Carr A, Byrom WD, Bilski AJ. A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol. 1998;15:433–445.
    1. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350:2441–2451. doi: 10.1056/NEJMoa032196.
    1. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2000;195:694–712. doi: 10.1016/S1072-7515(02)01491-6.
    1. Livrea P, Trojano M, Simone IL, Zimatore GB, Logroscino GC, Pisicchio L, Lojacono G, Colella R, Ceci A. Acute changes in blood CSF barrier permselectivity to serum protein after intrathecal methotrexate and CNS irradiation. J Neurol. 1985;231:336–339. doi: 10.1007/BF00313712.
    1. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21:55–89. doi: 10.1210/er.21.1.55.
    1. Fujii Y, Nakayama M. Reduction of postoperative nausea and vomiting and analgesic requirement with dexamethasone in women undergoing general anesthesia for mastectomy. Breast J. 2007;13:564–567. doi: 10.1111/j.1524-4741.2007.00497.x.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir